~ ~

i I I

R£FERf~CES

~ferences

8 REFERENCES

1. Abe F, Tateyma M, Shibuya H, Azumi Nand Ommura Y (1985) Experimental

candidiasis in iron overload. Mycopathologia 89: 59-63.

2. Aeed P A, Young CL, Nagiec MM, and. Elhammer Ap (2009) Inhibition of Inositol

Phosphorylceramide Synthase by the Cyclic Peptide Aureobasidin A. Antimicrob Agents

Chemother 53(2): 496-504.

3. Albertson GD, Niimi M, Cannon RD & Jenkinson H F (1996) Multiple efflux

mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents

Chemother 40: 2835-2841.

4. Almeida RS, Brunke S, Albrecht A, Thewes S, Laue M, Edwards JE, Filler SG and Hube

B (2008) The hyphal-associated adhesion and invasin Als3 of Candida albicans mediates

iron acquisition from host ferritin. PLoS Pathog 4: e1000217. - .

5. Almeida RS, Wilson D and Hube B (2009) Candida albicans iron acquisition within the

host FEMS Yeast Res 9 1000-1012.

6. Ansari S, Gupta P, Mahanty SK and Prasad R (1993) The Uptake of Amino Acids by erg

Mutants of Candida albicans. J Med Vet Mycol31: 377-386.

7. Arosio P, Adelman TG an Drysdale JW (1978) On ferritin heterogeneity. Further

evidence for heteropolymers. J Bioi Chem 253: 4451--4458.

8. Arosio P, Yokota M and Drysdale JW (1976) Structural and immunological relationships

of isoferritins in normal and malignant cells. Cancer Res 36: 1735-1739.

9. Arthington-Skaggs BA, Jradi H, Desai T & Morrison CJ (1999) Quantitation of

ergosterol content: novel method for determination of fluconazole susceptibility of

Candida albicans. J Clin Microbiol37: 3332-3337.

184

1?§ferences

1 O. Askwith C, Eide D, Van Ho A, Bernard PS, Li L, Davis-Kaplan S, Sipe DM, Kaplan J.

(1994) the FET3 gene of S cerevisiae encodes a multicopperoxidase required for ferrous

iron uptake. Cell 76: 403-410.

11. Bader T, Bodendorfer B, Schroppel K, and Morschhauser J (2007) Calcineurin I~

Essential for Virulence in Candida albicans Infection and Immunity 71(9): 5344-5354.

12. Baek YU, Li M and Davis DA (2008) Candida albicans ferric reductases an;

differentially regulated in response to distinct forms of iron limitation by the Rim 1 0 1 ane

CBF transcription factors. Eukaryot Cell 7: 1168-1179.

13. BailIe GS & Douglas LJ (1999) Role of dimorphism in the development of Candide.

albicans biofilms. J Med Micobiol48: 671-679.

14. Bali PK & Aisen P (1992) Receptor-induced switch in site-site cooperativity during iror

release by transferrin. Biochemistry 31: 3963-3967.

15. Banerjee D, Lelandais G, Shukla S, Mukhopadhyay G, Jacq C, Frederic Devaux Fane

Prasad R (2008) Responses of Pathogenic and Nonpathogenic Yeast Species to Steroid~

Reveal the Functioning and Evolution of Multidrug Resistance Transcriptional Networks

Eukaryot Cell 7 (1): 68-77.

16. Banerjee D, Pillai B, Karnani N, Mukhopadhyay G and Prasad R (2004) Genome-wide

expression profile of steroid response in Saccharomyces cerevisiae. Biochem Biophys Res

Commun. 317: 406-413.

17. Banin E, Vasil ML and Greenberg EP (2005) Iron and Pseudomonas aeruginosa biofilm

formation. PNAS 102: 11076-11081.

18. Banuett F (1998) Signalling in the yeast; an informational cascade with links to the

filamentous fungi. Mol. Bioi. Rev. 62; 249-274.

185

1?§ferences

19. Barluzzi R, Saleppico S, Nocentini A, Boelaert JR, Neglia R, Bistoni F and Blasi E

(2002) Iron overload exacerbates experimental meningoencephalitis by Cryptococcus

neoformans. J Neuroimmunol132: 140-146.

20. Barnes K, Dickstein B, Cutler GB, Fojo T and Bates SE (1996) Steroid accumulation,

and antagonism of P-glycoprtein in multi drug resistant cells. Biochemistry 35: 4820-

4827.

21. Bastidas RJ, Reedy JL, Johansson HM, Heitman J and Maria E. Cardenas ME (2008)

Signaling cascades as drug targets in model and pathogenic fungi Curr Opin lnvestig

Drugs. 9(8): 856-864.

22. Batova M, Borecka-Melkusova S, Simockova M, Dzugasova V, Gova E and Subik J

(2008) Functional characterization of the CgPGSl gene reveals a link between

mitochondrial phospholipid homeostasis and drug resistance in Candida glabrata Curr

Genet 53:313-322

23. Ben-Yaacov R, Knoller S, Caldwell GA, Becker JM and Koltin Y (1994) Candida

albicans gene encoding resistance to benomyl and methotrexate is a multi drug resistance

gene. Antimicrob Agents Chemother 38: 648-652.

24. Blankenship JR, Wormley, FL, Boyce MK, Schell WA, Filler SG, Perfect JR., and

Heitman J (2003) Calcineurin Is Essential for Candida albicans Survival in Serum and

Virulence Eukaryotic Cell 2(3): 422--430.

25. Bligh EG, and. Dyer WJ (1959). A rapid method of total lipid extraction and

purification. Can. J Biochem. Physiol. 37:911-917.

26. Bockmuhl DP, Krishnamurthy S, Gerads M, Sonneborn A and Ernst JF (2001) Distinct

and redundant roles of the two protein kinase A isoforms Tpkl p and Tpk2p in

morphogenesis and growth of Candida albicans. Mol Microbiol42: 1243-1257.

186

1?§ferences

27. Braun BR and Johnson AD (2000) TUP1, CPHl and EFGl make independent

contributions to filamentation in Candida albicans. Genetics 155: 57-67.

28. Breuer W, Epsztejn Sand Cabantchik ZI (1995) Iron acquired from transferring by K562

cells is delivered into a cytoplasmic pool of chelatable Iron (II). J Bioi Chern 270: 24209-

24215.

29. Brown AJ and Gow NA (1999) Regulatory networks controlling Candida albicans

morphogenesis. Trends Microbiol 7: 333-338.

30. Brown AJP and Gow NA (1999) Regulatory networks controlling Candida albicans

morphogenesis. Trends Microbiol7: 333-338.

31. Brown AJP (2002) Morphogenetic signaling pathways. In the book Candida and

Candidiasis. (Washington, D.C.:ASM press) pp:95-106.

32. Brown AJP and Gow NA (1999) Regulatory Netwoks Controlling Candida albicans

Morphogenesis. Trends Microbiol7: 333-338.

33. Brown DH, Guisani AD, Chen X and Kumamoto CA (1999) Filamentous Growth of

Candida albicans in Response to Physical Environmental Cues and Its Regulation by the

Unique CZFl Gene. Mol Microbiol18I: 7070-7079.

34. Bullen JJ, Rogers HJ, Spalding PB and Ward CG (2006) Natural resistance, iron and

infection: challenge for clinical medicine. J Med Microbiol55: 251-258.

35. Buss JL, Greene BT, Turner J, Torti FM and Torti SV (2004) Iron chelators in cancer

chemotherapy. Curro Top.Med. Chern. 4: 1623-1635.

36. Cabantchik ZI, Glickstein H, Milgram P and Breuer W (1996) A fluorescence assay for

assessing chelation of intracellular iron in a membrane model system and in mammalian

cells. Anal Biochern 233: 221-227.

187

~ferences

37. Calderone RA (2002) Candida and Candidiasis. Washington DC: American Society for

Microbiology Press.

38. Calera JA, Zhao XJ and Calderone R (2000) Defective hypha 1 development and

avirulence caused by a deletion of the SSKI response regulator gene in Candida albicans.

Infection and Immunity. 68: 518-525.

39. Catrin Stichtemoth and Joachim F. Ernst (2009) Hypoxic Adaptation by Efgl Regulates

Biofilm Formation by Candida albicans App Env Microbiol75 (11): 3663-3672

40. Cerbon J, Falcon A, Hem' Andez-Luna C and Segura-Cobos D (2005) Inositol

phosphoceramide synthase is a regulator of intracellular levels of diacylglycerol and

cerami de during the G 1 to S transition in Saccharomyces cerevisiae Biochem. 1. 388,

169-176.

41. Chandra J, Kuhn DM, Mukherjee PK Hoyer LL, McCormick T and Ghannoum MA

(2001a) Biofilm formation by the fungal pathogen Candida albicans-development,

architecture and drug resistance. J Bacteriol183: 5385-5394.

42. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Douglas LJ and Ghannoum MA

(2001b) Antifungal resistance of Candidal biofilms formed on denture acrylic in vitro. J

Dent Res 80: 903-908.

43. Chau AS, Gumani M, Hawkinson R, Laverdiere M, Cacciapuoti A and McNicholas PM

(2005) Inactivation of Sterol ~5,6-Desaturase Attenuates Virulence in Candida albicans

Antimicrob Agents Chemother 49: 3646-3651.

44. Chen CG, Yang YL, Shih HI, Su CL and Lo HJ (2004) CaNdt80 is involved in drug

resistance in Candida albicans by regulating CDRI. Antimicrob Agents Ch 48: 4505-

4512.

188

1?§ferences

45. Chen CG, Yang YL, Tseng KY, Shih HI, Liou CH, Lin CC and Lo HJ (2009) Replp

negatively regulating MDRI efflux pump involved in drug resistance in Candida

albicans. Fungal Genet BioI 46: 714-720.

46. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC and Colgan SP

(2002) Hypoxia-inducible factor-I-dependent regulation of the multi drug resistance

(MDRl) gene. Cancer Res. 62: 3387-3394.

47. Comerford KM and Colgan SP (2004a) Assessing oxygen sensitivity of the multidrug

resistance (MDR) gene. Methods Enzymol. 381: 376-387.

48. Comerford KM,Cummins EP and Taylor CT (2004b) c-Jun NH2-terminal kinase

activation contributes to hypoxia-inducible factor! a-dependent P-glycoprotein expression

in hypoxia. Cancer Res. 64: 9057-9061.

49. Coste AT, Turner V, Ischer F, Morschhauser J, Forche A, Selmecki A, Berman J, Bille J,

Sanglard D (2006) A mutation in Tac 1 p, a transcription factor regulating CDRI and

CDR2, is coupled with loss of heterozygosity at Chromosome 5 to mediate antifungal

resistance in Candida albicans. Genetics 172: 2139-2156.

50. Coste AT, Karababa M, Ischer F, Bille J and Sanglard D (2004) TAC1, transcriptional

activator of CDR genes, is a new transcription factor involved in the regulation of

Candida albicans ABC transporters CDRI and CDR2. Eukaryot Cell 3: 1639-1652.

51. Coste AT, Kararaba M, Ischer F, Bille J and Sanglard D. (2004) TAC], transcriptional

activator of CDR] genes, is a new transcription factor involved in the regulation of

Candida albicans ABC transporters CDR] and CDR2. Eukaryot Cell 3: 1639-1652.

52. Cowen LE (2009) Hsp90 Orchestrates Stress Response Signaling Governing Fungal Drug

Resistance PLoS Pathogens 5(7): el000532.

53. Cowena LE and Lindquist S (2005) Hsp90 potentiates the rapid evolution of new traits:

drug resistance in diverse fungi. Science 309 (5744): 2185-2189.

189

~ferences

54. Cowen LE, Singha SD, Ko·· hlerb JR, Collinsa C, Zaasc AK, Schellc W A, Azizc H,

Mylonakisd E, Perfectc,e JR, Whitesellf L and Susan L (2009) Harnessing Hsp90

function as a powerful, broadly effective therapeutic strategy for fungal infectious disease

Proc. Natl. Acad. Sci 106 (8): 2818-2823.

55. Craven RJ, Mallory JC, and Hand RA (2007) Regulation of Iron Homeostasis Mediated

by the Heme-binding Protein Dap 1 (Damage Resistance Protein 1) via the P450 Protein

ErglllCyp51 J BioI. Chem 282(50): 36543-36551

56. Cruz MC, Goldstein AL, Blankenship JR, Poeta MD, Davis D, Cardenas ME, Perfect JR,

McCusker JH and Heitman J (2002) Calcineurin is essential for survival during

membrane stress in Candida albicans. EMBO J 21(4): 546-559.

57. Csank C, Makris C, Meloche S, Schroppel K, Rollinghoff M, Dignard D, Thomas DY

and Whiteway M (1997) Derepressed hyphal growth and reduced virulence in a VH 1

family-related protein phosphatase mutant of the human pathogen Candida albicans. Mol

Bioi Cell 8(12): 2539-51.

58. Das M, and Datta A (1985) Steroid binding protein(s) in yeasts. Biochem. Int. 11: 171-

176.

59. Daum G, Lees N.D, Bard M and Dickson R (1998) Biochemistry, cell biology and

molecular biology oflipids of Saccharomyces cerevisiae. Yeast 14:1471-510.

60. Davis D (2003) Adaptation to environmental pH in Candida albicans and its relation to

pathogenesis. Curr Genet 44: 1-7

61. Davis D (2009) How human pathogenic fungi sense and adapt to pH: the link to virulence

Current Opinion in Microbiology. 12: 365-370.

62. de Micheli M, Bille J, Schueller C and Sanglard D. (2002) A common drug responsive

element mediates the upregulation of the Candida albicans ABC transporters CDR1 and

CDR2, two genes involved in antifungal drug resistance. Mol Microbiol43: 1197-1214.

190

~ferences

63. Del Sorbo G, Schoonbeek HJ and De Waard MA (2000) Fungal Transporters Involved in

Efflux of Natural Toxic Compounds and Fungicides. Fung Genet and Bioi 30: 1-15.

64. Devaiah, SP, Roth MR, Baughman E, Li M, Tamura P, Jeannotte R, Welti R and. Wang

X (2006). Quantitative profiling of polar glycerolipid species from organs of wild-type

Arabidopsis and a phospholipase Dalphal knockout mutant. Phytochemistry 67: 1907-

1924.

65. Doedt T, Krishnamurthy S, Bockmuhl DP, Tebarth B, Stenpel C, Russell CL, Brown AJP

and Ernst JF (2004) APSES proteins regulate morphogenesis and metabolism in Candida

albicans. Mol Bioi Cell 15: 3167-3180.

66. Doherty CP (2007) Host-pathogen interactions: the role ofiron.1 Nutr 137: 1341-1344.

67. Dunkel N, Blass J, Rogers PD and Morschhauser J (2008a) Mutations in the multi drug

resistance regulator MRRl, followed by loss of heterozygosity, are the main cause of

MDRI overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol

69: 827-840.

68. Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhauser J and Rogers PD (2008b) A

gain-of-function mutation in the transcription factor Upc2p causes upregulation of

ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida

albicans isolate. Eukaryot Cell 7: 1180-1190.

69. Eck R, Hundt S, Hartl A, Roemer E and Kunkel W (1999) A multi copper oxidase gene

from Candida albicans: cloning, characterization and disruption. Microbiology. 145:

2415-2422.

70. Ejsinga CS, Sampaioa JL, Surendranatha V, Duchoslavb E, Ekroosc K, Klemma RW,

Simonsa K, and Shevchenkoa A, (2009) Global analysis of the yeast lipidome by

quantitative shotgun mass spectrometry. Proc Natl Acad Sci 106 (7): 2136-2141

71. Emery T (1980) Iron deprivation as biological defense mechanism. Nature 287: 776-777.

191

r.R.gferences

72. Epsztejn S, Glickstein H, Picard V, Slotki IN, Breuer W, Beaumont C and Cabantchik ZI

(1999) H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress

response and induces multi drug resistance properties Blood 94: 3593-3603.

73. Ernst JF & Schmidt A (2000) Dimorphism in Human Pathogenic and Apathogenic

Yeasts. Karger, Switzerland.

74. Ernst JF (2000) Transcription factors III Candida albicans- environmental control of

morphogenesis. Microbiology 146: 1763-1774.

75. Espinell-Ingroff A, Barchiesi F, Hazen KC, Martinez-Suarez JV and Scalise G (1998)

Standardization of Antifungal Susceptibility Testing and Clinical Relevance. Med Mycol

1: 58-78

76. Evans DM, Frazer IH & Martin NG (1999) Genetic and environmental causes of

variation in basal levels of blood cells. Twin Res 2: 250-257.

77. Fang D, Bao Y, Li X, Liu F, Cai K, Gao J and Liao Q (2010) Effects ofIron Deprivation

on Multidrug Resistance of Leukemic K562 Cells Chemotherapy 56: 9-16.

78. Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser

C, Bader 0 and Sanglard D.et al. (2009) Gain of function mutations in CgPDRl of

Candida glabrata not only mediate antifungal resistance but also enhance virulence. PLoS

Pathog 5 (1): e1000268.

79. Ferreira C, Bucchini D, Martin ME, Levi S, Arosio P, Grandchamp B and Beaumont C

(2000) Early embryonic lethality of H ferritin gene deletion in mice. J Bioi Chem 275:

3021-3024.

80. Fischbach MA, Lin H, Liu DR & Walsh CT (2006) How pathogenic bacteria evade

mammalian sabotage in the battle for iron. Nat Chem Bioi 2: 132-138.

81. Fletcher J & Huehns ER (1968) Function of transferrin. Nature 218: 1211-1214.

192

~ferences

82. Fling ME, Kopf J, Tamarkin A, Gorman JA, Smith HA, Koltin Y (1991) Analysis of a

Candida albicans gene that encodes a novel mechanism for resistance to benomyl and

methotrexate. Mol Gen Genet 227:318-329.

83. Fonzi WA & Irwin MY (1993) Isogenic strain construction and gene mappmg m

Candida albicans. Genetics 134: 717-728.

84. Franz R, Kelly SL, Lamb DC, Kelly DE, Ruhnke M & Morschhauser J (1998) Multiple

molecular mechanisms contribute to a stepwise development of fluconazole resistance in

clinical Candida albicans strains. Antimicrob Agents Chemother 42: 3065-3072.

85. Franz R, Ruhnke M & Morschhauser J (1999) Molecular aspects of fluconazole

resistance development in Candida albicans. Mycoses 42: 453-458.

86. Fratti RA, Belanger PH, Ghannoum MA, Edwards JE Jr & Filler SG (1998) Endothelial

cell injury caused by Candida albicans is dependent on iron. Infect Immun 66: 191-196.

87. Frasco MB and Barrett JF (1998) Importance of Antifungal Drug-Resistance: Clinical

Significance and Need for Novel Therapy. Exp Opin Invest Drugs 7: 175-198.

88. Furuyama K, Kaneko K & Vargas PD (2007) Heme as a magnificent molecule with

multiple missions: heme determines its own fate and governs cellular homeostasis.

Tohoku J Exp Med213: 1-16.

89. Gaur NA, Puri N, Karnani N, Mukhopadhyay G, Goswami SK and Prasad R (2004)

Identification of a negative regulatory element which regulates basal transcription of a

multidrug resistance gene CDRI of Candida albicans. FEMS Yeast Res 4: 389-399.

90. Ghannoum M and Rice LB (1999) Antifungal Agents: Mode of Action, Mechanism of

Resistance and Correlation of These Mechanisms With Bacterial Resistance. Clin

Microbial Rev 12: 501-512.

193

~ferences

91. Gil ML, Casanova M & Martinez 1P (1994) Changes in the cell wall glycoprotein

composition of Candida albicans associated to the inhibition of the germ tube formation

by EDTA. Arch Microbiol161: 489-494.

92. Guan XL, Souza CM, Pichler H, Dewhurst G, Schaad 0, Kajiwara K, Wakabayashi H,

Ivanova T, Castillon GA, Piccolis M, Abe F, Loewith R, Funato K, Wenk MR, and

Riezman H (2009) Functional Interactions between Sphingolipids and Sterols III

Biological Membranes Regulating Cell Physiology Mol Bioi Cell. 20:2083-2095.

93. Gujjar PR, Finucane M and Larsen B (1997) The effect of estradiol on Candida albicans

growth. Ann. Clin. Lab. Sci. 27: 151-156.

94. Gupta V, Kohli AK, Krishnamurthy S, Puri N, Aalamgeer SA, Panwar SL and Prasad R

(1998). Identification of mutant alleles of CaMDRJ, a major facilitator of Candida

albicans which confers multi drug resistance and its in vitro transcriptional activation.

Curr Genet 34: 192-199.

95. Halliwell Band Gutteridge 1M (1984) Free radicals, lipid peroxidation and cell damage.

Lancet 2 (8411): 1095

96. Hameed S, Prasad T, Banerjee D, Chandra A, Mukhopadhyay CK, Goswami SK, Lattif

AA, Chandra J, Mukherjee PK, Ghannoum MA and Prasad R (2008) Iron deprivation

induces EFG J -mediated hypha 1 development in Candida albicans without affecting

biofilm formation. FEMS Yeast Res. 8:744-755.

97. Han Y (2005) Utilization of ferroproteins by Candida albicans during candidastasis by

apotransferrin. Arch Pharm Res 28: 963-969.

98. Heymann P, Gerads M, Schaller M, Dromer F, Winkelmann G and Ernst JF (2002) The

siderophore iron transporter of Candida albicans (Sitlp/Arnlp) mediates uptake of

ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun 70:

5246-5255.

194

1?gferences

99. Howard DH (1999) Acquisition, transport and storage of iron by pathogenic fungi. Clin

Mirobiol Rev 12: 394-404.

100.Hughes AL, Powell DW, Bard M, Eckstein J, Barbuch R, Link AJ and Espenshade PJ.

(2007) DapllPGRMCI binds and regulates cytochrome P450 enzymes. Cell Metab.

5(2): 143-9.

101. Hwang CS, Rhie G, Kim ST, Kim YR, Huh WK, Baek YU and Kang SO (1999) Copper­

and zinc-containing superoxide dismutase and its gene from Candida albicans. Biochim.

Biophys. Acta 1427:245-255.

102.Im YJ, Idkowiak-Baldys J, Thevissen K, Cammue BP and Takemoto lY.(2003) IPTl­

independent sphingolipid biosynthesis and yeast inhibition by syringomycin E and plant

defensin DmAMPl. FEMS Microbiol Lett. 223(2): 199-203.

103.Jain P, Akula I, and Edlind T (2003) Cyclic AMP Signaling Pathway Modulates

Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles

and Other Sterol Biosynthesis Inhibitors. Antimicrob Agents Chemother 47 (10): 3195-

3201

104. Kadosh D and Johnson AD (2001) Rfgl, a protein related to the Saccharomyces

cerevisiae hypoxic regulator Roxl, controls filamentous growth and virulence in Candida

albicans. Mol. Cell. Bioi. 21: 2496-2505.

105. Kakeya H, Miyazaki T, Miyazaki Y and Kohno S (2003) Azole resistance in Candida

spp. Nippon lshinkin Gakkai Zasshi. 44(2):87-92.

106. Kan VL, Geber A and Bennett, JE (1996) Enhanced oxidative killing of azole-resistant

Candida glabrata strains with ERG]] deletion. Antimicrob Agents Chemother 40: 1717-

1719.

195

r.R.gferences

107. Kamani N, Gaur NA, Jha S, Puri N, Krishnamurthy S, Goswami SK, Mukhopadhyay G

and Prasad R (2004). SREl and SRE2 are two specific steroid-responsive modules of

Candida drug resistance gene 1 (CDRl) promoter. Yeast 3: 219-239.

108. Kathleen MY, Chandra J, Cheng G, Mukherjee PK, Zhao X, Rodriguez-Zas SL, Kwast

KE, Ghannoum MA and Hoyer LL (2007) Temporal analysis of Candida albicans gene

expression during biofilm development. Microbiology 153: 2373-2385.

109. Kaur Rand Bachhawat AK (1999) The Yeast Multidrug Resistance Pump, Pdr5p,

Confers Reduced Drug Resistance in Erg Mutants of Saccharomyces cerevisiae.

Microbiology 145: 809-818.

Ito. Kelly SL, Lamb DC, Kelly DE, Manning NJ, Loeffler J, Hebart H, Schumacher U and

Einsele H (1997) Resistance to Fluconazole and Cross-Resistance to Amphotericin B in

Candida albicans From AIDS Patients Caused by Defective Sterol A5,6_ Desaturation.

FEBS Lett 400: 80-82.

III. Kerridge D (1985) The protoplast membrane and antifungal drugs. Fungal protoplasts:

applications in biochemistry and genetics. Marcel Deker, New York, 135-169.

112. Kerridge D (1986) Mode of action of clinically important antifungal drugs. Adv

Microbial Physiol27: 1-72.

113. Knight SA, Vilaire G, Lesuisse E and Dancis A (2005) Iron acquisition from transferrin

by Candida albicans depends on the reductive pathway. Infect Immun 73: 5482-5492.

114. Knight SAB and Dancis A (2006) Reduction of 2,3-bis(2-methoxy-4-nitro-5-

sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) is dependent on CaFRE 1 0

ferric reductase for Candida albicans grown in unbuffered media. Microbiology 152:

2301-2308.

196

CR.§ferences

1 1 5. Kobayashi D, Kondo K, Uehara N, Otokozawa S, Tsuji N, Yagihashi A and Watanabe N

(2002) Endogenous reactive oxygen species is an important mediator of miconazole

antifungal effect. Antimicrob Agents Chemother 46: 3113-17.

116. Kohler JR and Fink GR (1996) Candida albicans strains heterozygous and homozygous

for mutations in mitogen-activated protein kinase signaling components have defects in

hyphal development. Proc Natl A cad Sci. 93: 13223-8.

117. Kohli AK, Srnriti M, Mukhopadhyay K and Prasad R (2002) In vitro low-level resistance

to azoles in Candida albicans is associated with changes in membrane lipid fluidity and

asymmetry. Antimicrob Agents Chemother 46: 1046-1052.

l18.Kontoghiorghes GJ and Weinberg ED (1995) Iron: Mammalian defense systems,

mechanisms of disease and chelation therapy approaches. Blood Rev 9: 33-45.

119.Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, Manning JT and

Han X (2007) Increased bone marrow iron stores is an independent risk factor for

invasive aspergillosis in patients with high-risk hematologic malignancies and recipients

of allogeneic hematopoietic stem cell transplantation. Cancer 110: 1303-1306.

120. Kornitzer D (2009) Fungal mechanisms for host iron acquisition. Curr Opin Microb 12:

377-383.

121. Koshkin V and Greenberg ML (2002) Cardiolipin prevents rate-dependent uncoupling

and provides osmotic stability in yeast mitochondria. Biochem.J. 364, 317-322

122.Krishnamurthy S, Plaine A, Albert J, Prasad T, Prasad R and Ernst JF (2004) Dosage­

dependent functions of fatty acid desaturase Ole 1 p in growth and morphogenesis of

Candida albicans. Microbiology 150: 1991-2003.

123. Kuhn DM, Balkis MM, Chandra J, Mukherjee PK and Ghannoum MA (2002) Uses and

limitations of the XTT assay in studies of Candida growth and metabolism. J Clin

Microbiol41: 506-508.

197

1?§ferences

124. Kuipers ME, Beljaars L, Van BN, Vries HG, Heegsma J, Van Den Berg 11, Meijer DK

and Swart PJ (2002) Conditions influencing the in vitro antifungal activity of lactoferrin

combined with antimycotics against clinical isolates of Candida. Impact on the

development of buccal preparations oflactoferrin. APMlS. 110: 290-298.

125. Kuipers ME, De Vries HG, Eikelboom MC, Meijer DK and Swart PJ (1999) Synergistic

fungistatic effects of lactoferrin in combination with antifungal drugs against clinical

Candida isolates. Antimicrob.Agents Chemother 43: 2635-2641.

126. Kuipers ME, Heegsma J, Bakker HI, Meijer DK, Swart PJ, Frijlink EW, Eissens AC, de

Vries-Hospers HG, and Van Den Berg 11 (2002) Design and fungicidal activity of

mucoadhesive lactoferrin tablets for the treatment of oropharyngeal candidosis. Drug

Deliv. 9:31-38.

127. Kumamoto CA and Vinces MD (2005) Contributions of hyphae and hyphae-co-regulated

genes to Candida albicans virulence. Cell Microbiol7: 1546-1554.

128.Labialle S, Gayet L, Marthinet E, Rigal D and Baggetto LG (2003) Transcriptional

regulators of the human multi drug resistance 1 gene: recent reviews. Biochem.

Pharmacol. 64: 943-948.

129. Lamb DC, Kelly DE, Schunck W-H, Shyadehi AZ, Akhtar M, Lowe DJ, Baldwin BC &

Kelly SL (1997) The mutation T315A in Candida albicans sterol 14a-demethylase causes

reduced enzyme activity and fluconazole resistance through reduced affinity. J Bioi Chem

272: 5682-5688.

130.Lan CY, Rodarte G, Murillo LA, Jones T, Davis RW, Dungan J, Newport G, & Agabian

N 2004 (2004) Regulatory networks affected by iron availability in Candida albicans.

Mol Microbiol 53: 1451-1469.

131. Lesuisse E, Knight SA, Camadro JM and Dancis A (2002) Siderophore uptake by

Candida albicans: effect of serum treatment and comparison with Saccharomyces

cerevisiae. Yeast 19: 329-340. 198

CJ?gferences

132.Levi S, Yewdall SJ, Harrison PM, Santambrogio P, Cozzi A, Rovida E, Albertini A and

Arosio P (1992) Evidence of H- and Lchains have co-operative roles in the iron-uptake

mechanism of human ferritin. Biochem J 288: 591-596.

133.Li L and Kaplan J (1996) Characterization of Yeast Methyl Sterol Oxidase (ERG25) and

identification ofa Human Homologue. J Bioi Chern 271(28):16927-15933.

134.Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A and Fink GR (1997)

Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.

135.Lo HJ, Wang JS, Lin CY, Chen CG, Hsiao TY, Hsu CT, Su CL, Fann MJ, Ching YT and

Yang YL (2005) EFGl involved in drug resistance by regulating the expression of ERG3

in Candida albicans. Antimicrob Agents Chemother 49: 1413-15.

136.Low CP, Liew LP, Pervaiz S and Yang H (2005) Apoptosis and lipoapoptosis in the

fission yeast Schizosaccharomyces pombe. FEMS Yeast Res 5: 1199-1206.

137.Madani ND, Malloy PJ, Rodriguez-Pombo P, Krishnan AV and Feldman D. (1994)

Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is

inhibited by estradiol. Proc. Natl. Acad. Sci. 91: 922-926.

138.Maesaki S, Marichal P, Bossche HV, Sanglard D and Kohno S (1999) Rhodamine 6G

Efflux for the Detection of CDRI-Overexpressing Azole-Resistant Candida albicans

Strains. J Antimicrob Chemother 44: 27-31.

139. Mallory JC, Crudden G, Johnson BL, Caiqing MC, Charles A. Pierson CA, Bard M, and

Craven RJ. (2005) Dap1p, a Heme-Binding Protein That Regulates the Cytochrome P450

Protein Ergl1p/Cyp51p in Saccharomyces cerevisiae Mol. Cell. Bioi 25(5):1669-1679.

140.Malloy PJ, Zhao X, Madani ND and Feldman D (1993) Cloning and expression of the

gene from Candida albicans that encodes a high-affinity corticosteroid-binding protein.

Proc. Natl. Acad. Sci. 90: 1902-1906.

199

~ferences

141. Manoharlal R, Gaur NA, Panwar SL, Morschhausef· J and Prasad R (2008)

Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression

of CDR] in Azole-Resistant Candida albicans. Antimicrob Agents Chemother 52 (4):

1481-1492

142.Manoharlal R, Gorantala J, Shamrma M, Sanglard D and Prasad R (2010) PAPI (poly­

(A) polymerase) homozygosity and hyperadenylation are major determinants of increased

mRNA stability of CDRI in azole resistant clinical isolates of Candida albicans.

Microbiol156: 313-336

143. Marengo-Rowe AJ (2006) Structure-function relations of human hemoglobins.

Proceedings (Bayl Univ Med Cent) 19: 239-245.

144. Marichal P (1999) Mechanisms of Resistance to Azole Antifungal Compounds. Current

Opinion in Anti-infective Investigational Drugs 1: 318-333.

145. Marichal P, Bossche VR, Odds FC, Nobels G, Warnock DW, Timmerman V,

Broeckhoven VC, Fay S. and Mose-Larsen P (1997) Molecular Biological

Characterization of an Azole-Resistant Candida glabrata Isolate. Antimicrob Agents

Chemother 41: 2229-2237.

146.Martins MD and Rex JR (1997) Antifungal Drug Resistance: a Focus on Candida.

Clinical Updates in Fungal Infections 1: 1-6.

147. McCord 1M (1996) Effects of positive iron status at a cellular level. Nut. Rev 54(3): 85-

88.

148. Mekalanos JJ (1992) Environmental signals controlling expressIOn of virulence

determinants in bacteria. J Bacteriol17 4: 1-7.

149. Mishra P & Prasad R (1987) Alterations in fatty acyl composition can selectivity affect

amino acid transport in Saccharomyces cerevisiae. Biochem Int 15: 499-508.

200

CR,gferences

ISO. Mishra P & Prasad R (1989) Relationship between ethanol tolerance and fatty acyl

composition of Saccharomyces cerevisiae. Appl Microbiol Biotechnol30: 294-298.

151. Moelling C, Oberschlacke R, Ward P, Karijolich J, Borisova K, Bjelos N and Bergeron L

(2007) Metal-dependent repression of siderophore and biofilm formation in Actinomyces

naeslundii. FEMS Microbiol Lett 275: 214-220.

152.Monge AR, Roma'n E, Arana DM, PIa J and Nombela C (2009) Fungi sensmg

environmental stress. Clinical Microbiology and Infection. 15 (1): 17-19

153. Morgan EH (1979) Studies on the mechanism of iron release from transferrin. Biochim

Biophys Acta 580: 312-326.

154.Morschhauser J, Barker KS, Liu TT, Bla BWJ, Homayouni R and Rogers PD (2007) The

transcription factor Mrr I p controls expression of the MDR I efflux pump and mediates

multidrugresistance in Candida albicans. PLoS Pathog 3: e164.

ISS. Mukherjee PK, Zhou G, Munyon Rand Ghannoum MA (2005) Candida biofilm: a well­

designed protected environment. Med MycoI43:191-208.

156.Mukhopadhyay CK, Mazumder B and Fox PL (2000) Role of hypoxia-inducible factor-I

in transcriptional activation of ceruloplasmin by iron deficiency. J.BioI.Chem. 275:

21048-21054.

157. Mukhopadhyay CK, Kohli AK and Prasad R (2002) Drug susceptibilities of yeast cells

are affected by membrane lipid composition. Antimicrob Agents Chemother 46: 3695-

3705.

158.Mukhopadhyay CK, Prasad T, Saini P, Pucadyil TJ, Chattopadhyay A and Prasad R

(2004) Membrane Sphingolipid-Ergosterol Interactions Are Important Determinants of

Multidrug Resistance in Candida albicans. Antimicrob Agents Chemother 48: 1778-

1787.

201

CR,gferences

159. Murphy DJ and Vance J (1999) Mechanisms of lipid-body formation. Trends Biochem

Sci. 24(3): 109-15.

160. Nyi1assi I, Papp T, Tako M, Nagy E and Vagvolgyi C (2005) Iron gathering of

opportunistic pathogenic fungi. A mini review. Acta Microbiol Immunol Hung 52: 185-

197.

161. Odds FC (1988) Candida and Candidosis: A Review and Bibliography (London).

162.Pao SS, Paulsen IT and Saier MHJr (1998) Major Facilitator Superfamily. Microbiol Mol

Bioi Rev 62: 1-34.

163.Park SH, Koh SS, Chun JH, Hwang HJ and Kang HS (1999) Nrg1 is a transcriptional

repressor for glucose repression of STAI gene expression in Saccharomyces cerevisiae.

Mol Cell BioI. 19: 2044-50.

164. Patrauchan MA, Sarkisova SA and Franklin MJ (2007) Strain-specific proteome response

of Pseudomon,as aeruginosa to biofilm-assosiated growth and to calcium. Microbiology

153: 3838-3851.

165. Pendrak ML and Roberts DD (2007) Hemoglobin is an effective inducer of hyphal

differentiation in Candida albicans. Med Mycol45: 65-71.

166.Pendrak ML, Chao MP, Van SS and Roberts DD (2004a) Heme oxygenase in Candida

albicans is regulated by hemoglobin and is necessary for metabolism of exogenous heme

and hemoglobin to alpha-biliverdin. J Bioi Chern 279: 3426-3433.

167. Pendrak ML, Van SS and Roberts DD (2004b) Sensing the host environment: recognition

of hemoglobin by the pathogenic yeast Candida albicans. Arch Biochem Biophys 426:

148-156.

202

~ferences

168.Perepnikhatka V, Fischer Fl, Niimi M, Baker RA, Cannon RD, Wang YK, Sherman F

and Rustchenko E (1999) Specific Chromosome Alterations in Fluconazole-Resistant

Mutants of Candida albicans. J Bacteriol181: 4041-4049.

169. Perrone GG, Tan SX and Dawes IW (2008) Reactive oxygen species and yeast apoptosis.

Biochim. Biophys. Acta. 1783: 1354-1368.

170. Pfaller MA and Diekema Dl (2007) Epidemiology of invasive candidiasis: a persistent

873 public health problem. Clin. Microbiol. Rev. 20: 133-163.

171.Posey lE and Gherardini FC (2000) Lack of role of iron in Lyme disease pathogen.

Science 288 (54710): 1651- 1653.

172.Prasad R (1991) Candida albicans: Cellular and Molecular Biology. Springer-Verlag,

Berlin.

173. Prasad R, De WP, Goffeau A and Balzi E (1995) Molecular cloning and characterization

of novel gene of Candida albicans, CDRI Conferring multiple resistance to drugs and

antifungals. Curro Genet. 27:320-329.

174. Prasad R, Gupta N and Gaur M (2004) Molecular basis of antifungal resistance III

pathogenic fungi. p. 357-414. In G. San-BIas and R. A. Calderone (ed.), Pathogenic fungi

-Host interactions and emerging strategies for control, Caister Academic Press, England.

175. Prasad R, Panwar SL and Krishnamurthy S (2000) Drug Resistance Mechanisms Of

Human Pathogenic Fungi -IN The Book by Marcel Dekker- "Fungal Pathogenesis:

Principles and Clinical Applications ".

176. Prasad T, Hameed S, Manoharlal R, Biswas S, Mukhopadhyay CK, Goswami SK and

Prasad R (2010) Morphogenic Regulator EFG 1 Affects Drug Susceptibilities of

Pathogenic Candida albicans FEMS Yeast Res. : epub.

203

<R.§ferences

177. Prasad T, Chandra A, Mukhopadhyay CK and Prasad R (2006) Unexpected link between

iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and

drug diffusion, leading to drug-susceptible cells. Antimicrob Agents Chemother 50: 3597-

3606.

178. Prasad T, Saini P, Gaur NA, Vishwakarma RA, Khan LA, Haq QM and Prasad R (2005)

Functional analysis of CaIPTl, a sphingolipid biosynthetic gene involved in multidrug

resistance and morphogenesis of Candida albicans. Antimicrob Agents Chemother 49:

3442-3452.

179. Radisky D and Kaplan J (1999) Regulation of transition metal across the yeast plasma

membrane. J Bioi Chem 274: 4481-4484.

180. Ramage G, Matrinez JP and Lopez-Ribot JL (2006) Candida biofilms on implanted

biomaterials: a clinically significant problem. FEMS Yeast Res 6: 979-986.

181. Ramage G, Vande WK, Wickes BL and Lopez-Ribot JL (2001) Standardized method for

in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrobial

Agents and Chemotherapy 45: 2475- 2479.

182.Ramage G, VandeWalle K, Lopez-Ribot JL and Wickes BL (2002) The filamentation

pathway controlled by the Efgl regulator protein is required for normal biofilm formation

and development in Candida albicans. FEMS Microbiol Lett 214: 95-100.

183.Ramage G, Wickes BL and Lopez-Ribot JL (2007) Inhibition on Candida albicans

biofilm formation using divalent cation chelators (EDTA). Mycopathol164: 301-306.

184. Ramanan N and Wang Y (2000) A high-affinity iron permease essential for Candida

albicans virulence. Science 288: 1062-1064.

204

~ferences

185. Rex JH, Pfaller MA, Galgiani IN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA,

Lancaster M, Odds FC, Rinaldi MG, Walsh TJ and Barry AL (1997) Development of

Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework

and Analysis of In Vitro-In Vivo Corrrelation Data for Fluconazole, ltraconazole and

Candida Infections. Clin Infect Dis 24: 235-247.

186. Reynolds TB and Fink RG (2001) Baker's yeast, a model for fungal biofilm formation.

Science 291: 878-881

187.Robbins N, Collins C, Morhayim J, Leah E. Cowen LE (2010) Metabolic control of

antifungal drug resistance. Fungal Genet. Bioi 47 (2): 81-93

188.Roepe PD (2001) pH and multi drug resistance. Novartis Found Symp. 240: 232-47

189.Romani L, Bistoni F, Puccetti P (2003) Adaptation of Candida albicans to the host

environment: the role of morphogenesis in virulence and survival in mammalian hosts.

Curro Opin. Microbiol. 6: 338-343.

190.Rosa JL, Victor L. Boyartchuk, Zhu LJ and Kaufman PD (2010) Histone

acetyltransferase Rttl09 is required for Candida albicans pathogenesis Proc. Nat!. Acad.

Sci 107 (4): 1594-1599.

191.Rouault TA and Tong WH (2008) Iron-sulfur cluster biogenesis and human disease.

Trends Genet 24: 398-407.

192. Ruprich-Robert G, Chapeland-Leclerc F, Boisnard S, Florent M, Bories G and Papon N

(2008) Contributions of the response regulators Ssk1p and Skn7p in the pseudohyphal

development, stress adaptation, and drug sensitivity of the opportunistic yeast Candida

lusitaniae. Eukaryot Cell 7:1071-4.

205

1?§ferences

193.Russell NJ, Evans RI, Steeg PF, Hellemons J, Verheul A and Abee T. (1995)

Membranes as a target for stress adaptation. Int J Food Microbiol. 28(2):255-61.

194. Sabie FT and Gadd GM (1992) Effect of nucleosides and nucleotides and the relationship

between cellular adenosine 3', 5'-cyclic monophosphate (cyclic AMP) and germ tube

formation in Candida albicans. Mycopathologia. 119: 147-56.

195. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning, a laboratory manual.

Cold Spring Harbor Laboratory Press, New York.

196. Sanglard D, Ischer F, Monod M and Bille J (1997) Cloning of Candida albicans genes

conferring resistance to azole antifungal agents: characterization of CDR 2 , a new

multi drug ABC transporter gene. Microbiology 143: 405-416.

197. Sanglard D, Ischer F, Monod M and Bille J (1996) Susceptibilities of Candida albicans

Multidrug Transporter Mutants to Various Antifungal Agents and Other Metabolic

Inhibitors. Antimicrob Agents Chemother 40: 2300-2305.

198. Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M and Bille J. (1995) Mechanisms

of Resistance to Azole Antifungal Agents in Candida albicans Isolates From AIDS

Patients Involve Specific Multidrug Transporters. Antimicrob Agents Chemother 39:

2378-2386.

199. Santos R, Buisson N, Knight S, Dancis A, Camadro JM and Lesuisse E (2003) Haemin

uptake and use as an iron source by Candida albicans: role of CaHMXl-encoded haem

oxygenase. Microbiology 149: 579-588.

200. Schaible UE and Kaufmann SHE (2004) Iron and microbial infection. Nat Rev Microbiol

2: 46-54.

201. Schrettl M, Kim HS, Eisendle M Kragl c, Nierman WC, Heinekamp T, Werner ER

Jacobsen I, Illmer P, Yi H, Brakhage AA and Haas H (2008) SreA-mediated irOl

regulation in Aspergillus fumigatus. Mol Microbiol70: 27-43.

206

CRgferences

202. Setiadi ER, Doedt T, Cottier F, Noffz C and Ernst JF (2006) Transcriptional response of

Candida albicans to hypoxia: linkage of oxygen sensing and Efg 1 p-regulatory networks.

J Mol Bioi 361: 399-411

203.Sharkey LL, McNemar MD, Saporito-Irwin SM, Sypherd PS and Fonzi WA (1999)

HWP 1 functions in the morphological development of Candida albicans downstream of

EFGl, TUPl, and RBFl. J Bacteriol181: 5273-9.

204. Shea JM and Poeta MD (2006) Lipid signaling III pathogenic fungi Curr Opin

Microbiol, 9:352-358

205. Silver PM, Oliver BG and White TC (2004) Role of Candida albicans transcription

factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell 3: 1391-1397.

206. Singh A, Prasad T, Kapoor K, MandaI A, Roth M, Welti R and Prasad R (2010)

Phospholipidome of Candida: Each species of Candida has distinctive phospholipid

molecular species. Omics (in press).

207. Skovsgaard T, Nielsen D, Maare C and Wasserman K (1994) Cellular Resistance to

Cancer Chemotherapy. Int Rev Cyto1156: 77-157.

208. Smith RL and Johnson AD (2000) Turning genes off by Ssn6-Tup 1: a conserved system

of transcriptional repression in eukaryotes. Trends Biochem Sci. 25: 325-30.

209. Sonneborn A, Bockmuhl DP and Ernst JF (1999a) Chlamydospore formation in Candida

albicans requires the Efg1 p morphogenetic regulator. Infect Immun 67: 5514-5517.

210. Sonneborn A, Bockmuhl DP, Gerads M, Kurpanek K, Sanglard D and Ernst JF (2000)

Protein Kinase A Encoded by TPK2 Regulates Dimorphism of Candida albicans. Mol

Microbiol35: 386-396.

207

~ferences

211. Sonneborn A, Tebarth B and Ernst JF (1999b) Control of white-opaque phenotypic

switching in Candida albicans by the Efglp morphogenetic regulator. Infect Immun 67:

4655-4660.

212.Sosinska GJ, de Groot PWJ, Joost M, de Mattos T, Dekker HL, de Koster CG,

Hellingwerf KJ and Klis FM (2008) Hypoxic conditions and iron restriction affect the

cell-wall proteome of Candida albicans grown under vagina-simulative conditions

Microbiology 154: 510-520.

213. Spacek J, Jilek P, Buchta V, Forstl M, Hronek M and Holeckova M. (2005) The serum

levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal

candidosis during attack, remission and in healthy controls. Mycoses. 48: 391-395.

214. Stanhill A, Schick N and Engelberg D (1999) The yeast ras/cyclic AMP pathway induces

invasive growth by suppressing the cellular stress response. Mol Cell Bio!. 19: 7529-38.

215. Stathopoulos-Gerontides A, Guo JJ, and Cyert MS (1999) Yeast ca1cineurin regulates

nuclear localization of the Crzl p transcription factor through dephosphorylation. Genes

Dev.13:798-803.

216. Stearman R (1996) A permease-oxidase complex involved in high-affinity iron uptake in

yeast. Science 271: 1552-1557.

217. Steinbach WJ, Reedy JL, Cramer RAPerfect JR, and Heitman J (2007) Harnessing

calcineurin as a novel anti-infective agent against invasive fungal infections. Nat. Rev.

Microbio!. 5:418-430.

218. Stoldt VR, Sonneborn A, Leuker CE and Ernst JF (1997) Efg 1 p, an essential regulator of

morphogenesis of the human pathogen Candida albicans, is a member of a conserved

class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J 16: 1982-

1991.

208

CR.fferences

219. Sugimoto Y, Sakoh H and Yamada K (2004) IPC Synthase as a Useful Target for

Antifungal Drugs. Curr Drug Tar - Infect Dis 4(4): 311-322.

220. Sukhai M and Miller MP (2000) Regulation of the multidrug resistance genes by stress

signals. J. Pharm. Pharm. Sci. 3: 268-280.

221. Sun S and Chasteen ND (1992) F erroxidase kinetics of horse spleen apoferritin. J Bioi

Chem267:25l60-25l66.

222. Sweet SP and Douglas LJ (1991) Effect of iron deprivation on surface composition and

virulence determinants of Candida albicans. J Gen Microbiol137: 859-865.

223. Talibi D and Raymond M (1999) Isolation of a putative Candida albicans transcriptional

regulator involved in pleiotropic drug resistance by functional complementation of a pdr 1

pdr3 mutation in Saccharomyces cerevisiae. J Bacteriol181: 231-240.

224. Thakur JK, Arthanari H, Yang F, Pan SJ, Fan X, Breger J, Frueh DP, Gulshan K, Li DK,

Mylonakis E, Struhl K, Rowley WSM, Cormack BP, Wagner G and Naar AM (2008) A

nuclear receptor like pathway regulating multidrug resistance in fungi. Nature 452: 604-

609.

225. Torelli R, Posteraro B, Ferrari S La Sorda M, Fadda G, Sanglard D and Sanguinettu M

(2008) The A TP-binding cassette transporter-encoding gene CgSNQ2 is contributor to

the CgPdrl-dependent azole resistance in Candida glabrata. Mol Microbiol 68: 186-20 l.

226. Torti FM@)Torti SV (2002) Regulation of ferritin genes and protein. Blood 99: 3505-

3516.

227. Tsai HF, Krol AA, Sarti KE and Bennett JE (2006) Candida glabrata PDR1, a

transcriptional regulator of a pleiotropic drug resistance network, mediates azole

resistance in clinical isolates and petite mutants. Antimicrob Agents 50: 1384-1392.

209

CRgferences

228. Vanden Bossche Hand Koymans L (1998) Cytochromes P450 in Fungi. Mycoses 41: 32-

38.

229. Vanden Bossche H, Willemsens G and Marichal P (1987) Anti-Candida drugs- the

biochemical basis for their activity. Crit Rev MicrobiollS (1) : 57-72.

230. Vazquez N, Walsh TJ, Friedman D, Chanock SJ, and Lyman CA (1998) Interleukin-15

augments superoxide production and microbicidal activity of human monocytes against

Candida albicans.Infect.Immun. 66:145-150.

231. Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD and Rogers PD (2006)

Pdrl regulates multi drug resistance in Candida glabrata: gene disruption and genome­

wide expression studies. Mol Microbiol 61: 704-722.

232. Vinolo MA, Hatanaka E, Lambertucci RH, Newsholme P and Curi R (2009) Effects of

short chain fatty acids on effector mechanisms of neutrophils.Cell Biochem Funct 27:48-

55.

233. Vorl and LH, Ulvatne H, Andersen J, Haukland HH, Rekdal 0, Svendsen JS and

Gutteberg TJ (1999) Antibacterial effects of lactoferricin B. Scand J Infect Dis 31: 179-

184.

234. Weinberg ED (1984) Iron withholding: a defense against infection and neoplasia. Physiol

Rev 64: 65-102.

235. Weinberg ED (1999a) The role of iron in protozoa and fungal infectious diseases. J

Eukaryot Microbiol46: 231-238.

236. Weinberg ED (1999b) Iron loading and disease surveillance. Emerg Infect Dis S: 346-

352.

210

1?§ferences

237. Weissman Z, Shemer R and Kornitzer D (2002) Deletion of the copper transporter

CaCCC2 reveals two distinct pathways for iron acquisition in Candida albicans. Mol

Microbiol44: 1551-1560.

238. Weissman Z, Shemer R, Conibear E and Kornitzer D (2008) An endocytic mechanism

for haemoglobin-iron acquisition in Candida albicans. Mol Microbiol. 61 (1): 201-217.

239. Welch KD, Van Eden ME and Aust SD (2001) Modification of ferritin during iron

loading. Free Radical Bioi Med 31: 999-1006.

240. Welti R, Li W, Li M, Sang Y, Biesiada H, Zhou HE, Rajashekar CB, Williams TD and ----Wang X (2002). Profiling membrane lipids in plant stress -responses. Role of

phospholipase D alpha in freezing-induced lipid changes in Arabidopsis. 1. Bioi. Chem.

277:31994-32002.

241. White TC (1997) Increased mRNA Levels of ERG 16, CDRs, and MDR1 Correlate With

Increased Azole Resistance in Candida albicans Isolates From a Patient Infected With

Human Immunodeficiency Virus. Antimicrob Agents Chemother 41: 1482-1487.

242. White TC, Holleman S, Dy F, Mirels LF and Stevens DA (2002) Resistance mechanisms

in clinical isolates of Candida albicans. Antimicrob Agents Chemother 46: 1704-1713.

243. White TC, Marr KA and Bowden RA (1998) Clinical, Cellular, and Molecular Factors

That Contribute to Antifungal Drug Resistance. Clin Microbiol Rev 11: 382-402.

244. Whiteway M (2000) Transcriptional Control of Cell Type and Morphogenesis in Candida

albicans. Curr Op in Microbiol3: 582-588. --245. Whiteway M, Dignard D and Thomas DY (1992) Dominant negative selection of

heterologous genes: isolation of Candida albicans genes that interfere with

Saccharomyces cerevisiae mating factor-induced cell cycle arrest. Proc Natl Acad Sci 89:

9410-4.

211

1?§ferences

246. Wu :XZ, Cheng AX, Sun LM, Sun SJ, Lou HX (2009) Plagiochin E, an antifungal

bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced

reactive oxygen species accumulation in Candida albicans Biochimica et Biophysica Acta

1790: 770-777.

247.Xu Y, Wang Y, Van L, Liang RM, Dai BD, Tang RJ, Gao PH and Yuan-Ying Jiang YY

(2009) Proteomic Analysis Reveals a Synergistic Mechanism of Fluconazole and

Berberine against Fluconazole-Resistant Candida albicans: Endogenous ROS

Augmentation Proteome Res. 8 (11): 5296-5304.

248. Yaacov RB, Knoller S, Caldwell GA, Becker JM and Koltin Y (1994) Candida albicans

gene encoding resistance to benomyl and methotrexate is a multidrug resistance gene.

Antimicrob Agents Chemother 38:648-652.

249. Yeater KM, Chandra J, Cheng G, Mukherjee PK, Zhao X, Sandra L. Zas R, KE,

Ghannoum MA and Hoyer LL (2007) Temporal analysis of Candida albicans gene

expression during biofilm development. Microbiology 153: 2373-2385.

250.Zhang Q, Chieu HK, Low CP, Zhang S, Heng CK, and Yang H (2003)

Schizosaccharomyces pombe Cells Deficient in Triacylglycerols Synthesis Undergo

Apoptosis upon Entry into the Stationary Phase. J Bio!. Chem. 278(47): 47145-47155.

251. Zhang X, Essman M, Burt ET and Larsen B (2000) Estrogen effects on Candida albicans:

a potential virulence-regulating mechanism. J Infect. Dis. 181: 1441-1446.

252.Zweytick D, Leitner E, Kohlwein SD, Yu C, Rothblatt J and Daum G. (2000)

Contribution of Are 1 p and Are2p to steryl ester synthesis in the yeast Saccharomyces

cerevisiae. Eur. J Biochem. 267, 1075-1082.

212